Noesis Capital Mangement’s Pfizer PFE Stock Holding History

Noesis Capital Mangement’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,225	Closed	-$343K	–	130
2026 Q1	$343K	Sell	12,225 -1,580	-11%	-$42.1K	0.05%	90
2025 Q4	$344K	Buy	13,805 +175	+1%	+$4.41K	0.05%	91
2025 Q3	$347K	Sell	13,630 -56	-0.4%	-$1.38K	0.05%	86
2025 Q2	$332K	Sell	13,686 -1,440	-10%	-$33.6K	0.06%	89
2025 Q1	$383K	Sell	15,126 -1,231	-8%	-$32.2K	0.08%	81
2024 Q4	$434K	Buy	16,357 +413	+3%	+$11.2K	0.08%	74
2024 Q3	$461K	Buy	15,944 +354	+2%	+$10.3K	0.09%	71
2024 Q2	$436K	Buy	15,590 +602	+4%	+$16.6K	0.1%	69
2024 Q1	$416K	Sell	14,988 -1,649	-10%	-$45.8K	0.09%	68
2023 Q4	$479K	Buy	16,637 +200	+1%	+$6.05K	0.11%	66
2023 Q3	$545K	Hold	16,437	–	–	0.14%	63
2023 Q2	$603K	Sell	16,437 -655	-4%	-$25.5K	0.15%	62
2023 Q1	$697K	Buy	17,092 +133	+0.8%	+$5.74K	0.18%	56
2022 Q4	$869K	Sell	16,959 -17	-0.1%	-$815	0.25%	49
2022 Q3	$743K	Sell	16,976 -98	-0.6%	-$4.76K	0.23%	49
2022 Q2	$895K	Sell	17,074 -300	-2%	-$15.3K	0.27%	47
2022 Q1	$899K	Sell	17,374 -1,095	-6%	-$56.8K	0.22%	48
2021 Q4	$1.09M	Sell	18,469 -631	-3%	-$31.3K	0.22%	49
2021 Q3	$821K	Sell	19,100 -310	-2%	-$13.7K	0.16%	57
2021 Q2	$783K	Sell	19,410 -109	-0.6%	-$4.24K	0.16%	56
2021 Q1	$707K	Sell	19,519 -450	-2%	-$16K	0.16%	57
2020 Q4	$735K	Sell	19,969 -989	-5%	-$36.3K	0.18%	56
2020 Q3	$730K	Sell	20,958 -941	-4%	-$33K	0.21%	54
2020 Q2	$679K	Sell	21,899 -885	-4%	-$30.1K	0.21%	53
2020 Q1	$706K	Buy	22,784 +316	+1%	+$10.8K	0.26%	47
2019 Q4	$835K	Buy	22,468 +115	+0.5%	+$4.1K	0.23%	52
2019 Q3	$762K	Sell	22,353 -685	-3%	-$24.9K	0.25%	48
2019 Q2	$947K	Sell	23,038 -3,249	-12%	-$129K	0.32%	43
2019 Q1	$1.06M	Buy	26,287 +624	+2%	+$25K	0.38%	44
2018 Q4	$1.06M	Sell	25,663 -29	-0.1%	-$1.2K	0.43%	40
2018 Q3	$1.07M	Sell	25,692 -2,823	-10%	-$109K	0.38%	41
2018 Q2	$982K	Sell	28,515 -2,690	-9%	-$91.9K	0.36%	44
2018 Q1	$1.05M	Buy	31,205 +125	+0.4%	+$4.3K	0.39%	42
2017 Q4	$1.07M	Sell	31,080 -1,954	-6%	-$66.6K	0.38%	43
2017 Q3	$1.12M	Buy	33,034 +256	+0.8%	+$8.23K	0.42%	45
2017 Q2	$1.04M	Sell	32,778 -2,002	-6%	-$63.1K	0.4%	46
2017 Q1	$1.13M	Buy	34,780 +82	+0.2%	+$2.58K	0.43%	47
2016 Q4	$1.07M	Buy	34,698 +699	+2%	+$21.3K	0.45%	43
2016 Q3	$1.09M	Buy	33,999 +817	+2%	+$27.3K	0.47%	43
2016 Q2	$1.11M	Sell	33,182 -658	-2%	-$21K	0.49%	42
2016 Q1	$952K	Buy	33,840 +1,252	+4%	+$35.8K	0.43%	42
2015 Q4	$998K	Sell	32,588 -67	-0.2%	-$2.11K	0.47%	40
2015 Q3	$973K	Sell	32,655 -24,252	-43%	-$778K	0.51%	39
2015 Q2	$1.81M	Sell	56,907 -530	-0.9%	-$17.3K	0.78%	29
2015 Q1	$1.9M	Sell	57,437 -768	-1%	-$24.4K	0.78%	30
2014 Q4	$1.72M	Sell	58,205 -3,351	-5%	-$96.1K	0.72%	32
2014 Q3	$1.73M	Sell	61,556 -6,705	-10%	-$188K	0.75%	32
2014 Q2	$1.92M	Buy	68,261 +3,707	+6%	+$106K	0.87%	30
2014 Q1	$1.97M	Sell	64,554 -5,911	-8%	-$176K	0.97%	27
2013 Q4	$2.05M	Sell	70,465 -1,111	-2%	-$32.3K	1.01%	27
2013 Q3	$1.95M	Sell	71,576 -4,016	-5%	-$109K	1.03%	29
2013 Q2	$2.01M	Buy	+75,592	New	+$2.09M	1.07%	27

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Noesis Capital Mangement's PFE Position: Q2 2026 in Review

Noesis Capital Mangement sold out of Pfizer (PFE) in Q2 2026, closing a stake of 12,225 shares — an estimated $343K sold.

Noesis Capital Mangement first reported a position in PFE in Q2 2013 and held it in 52 quarters. The position peaked at $2.05M in Q4 2013. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Noesis Capital Mangement reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
Noesis Capital Mangement sold 12,225 Pfizer shares in Q2 2026, an estimated $343K.
Noesis Capital Mangement first reported a position in Pfizer in Q2 2013 and held it in 52 quarters.
Noesis Capital Mangement's Pfizer position peaked at $2.05M in Q4 2013.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Noesis Capital Mangement's 13F filing for Q2 2026, filed 4 Aug 2026.